These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 31588244)

  • 1. Generation of hepatic spheroids using human hepatocyte-derived liver progenitor-like cells for hepatotoxicity screening.
    Wang Z; Li W; Jing H; Ding M; Fu G; Yuan T; Huang W; Dai M; Tang D; Zeng M; Chen Y; Zhang H; Zhu X; Peng Y; Li Q; Yu WF; Yan HX; Zhai B
    Theranostics; 2019; 9(22):6690-6705. PubMed ID: 31588244
    [No Abstract]   [Full Text] [Related]  

  • 2. Human Upcyte Hepatocytes: Characterization of the Hepatic Phenotype and Evaluation for Acute and Long-Term Hepatotoxicity Routine Testing.
    Tolosa L; Gómez-Lechón MJ; López S; Guzmán C; Castell JV; Donato MT; Jover R
    Toxicol Sci; 2016 Jul; 152(1):214-29. PubMed ID: 27208088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 3D in vitro model of differentiated HepG2 cell spheroids with improved liver-like properties for repeated dose high-throughput toxicity studies.
    Ramaiahgari SC; den Braver MW; Herpers B; Terpstra V; Commandeur JN; van de Water B; Price LS
    Arch Toxicol; 2014 May; 88(5):1083-95. PubMed ID: 24599296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Hepatic 2D Sandwich Cultures and 3D Spheroids for Long-term Toxicity Applications: A Multicenter Study.
    Bell CC; Dankers ACA; Lauschke VM; Sison-Young R; Jenkins R; Rowe C; Goldring CE; Park K; Regan SL; Walker T; Schofield C; Baze A; Foster AJ; Williams DP; van de Ven AWM; Jacobs F; Houdt JV; Lähteenmäki T; Snoeys J; Juhila S; Richert L; Ingelman-Sundberg M
    Toxicol Sci; 2018 Apr; 162(2):655-666. PubMed ID: 29329425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An in vitro expansion system for generation of human iPS cell-derived hepatic progenitor-like cells exhibiting a bipotent differentiation potential.
    Yanagida A; Ito K; Chikada H; Nakauchi H; Kamiya A
    PLoS One; 2013; 8(7):e67541. PubMed ID: 23935837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary-like human hepatocytes genetically engineered to obtain proliferation competence display hepatic differentiation characteristics in monolayer and organotypical spheroid cultures.
    Herzog N; Hansen M; Miethbauer S; Schmidtke KU; Anderer U; Lupp A; Sperling S; Seehofer D; Damm G; Scheibner K; Küpper JH
    Cell Biol Int; 2016 Mar; 40(3):341-53. PubMed ID: 26715207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of drug-induced immune-mediated hepatotoxicity using hepatocyte-like cells derived from human embryonic stem cells.
    Kim DE; Jang MJ; Kim YR; Lee JY; Cho EB; Kim E; Kim Y; Kim MY; Jeong WI; Kim S; Han YM; Lee SH
    Toxicology; 2017 Jul; 387():1-9. PubMed ID: 28645575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug metabolic activity is a critical cell-intrinsic determinant for selection of hepatocytes during long-term culture.
    Akiyama S; Saku N; Miyata S; Ite K; Toyoda M; Kimura T; Kuroda M; Nakazawa A; Kasahara M; Nonaka H; Kamiya A; Kiyono T; Kobayshi T; Murakami Y; Umezawa A
    Stem Cell Res Ther; 2022 Mar; 13(1):104. PubMed ID: 35279203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human hepatocytes derived from pluripotent stem cells: a promising cell model for drug hepatotoxicity screening.
    Gómez-Lechón MJ; Tolosa L
    Arch Toxicol; 2016 Sep; 90(9):2049-2061. PubMed ID: 27325232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-throughput confocal imaging of differentiated 3D liver-like spheroid cellular stress response reporters for identification of drug-induced liver injury liability.
    Hiemstra S; Ramaiahgari SC; Wink S; Callegaro G; Coonen M; Meerman J; Jennen D; van den Nieuwendijk K; Dankers A; Snoeys J; de Bont H; Price L; van de Water B
    Arch Toxicol; 2019 Oct; 93(10):2895-2911. PubMed ID: 31552476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and expansion of human pluripotent stem cell-derived hepatic progenitor cells by growth factor defined serum-free culture conditions.
    Fukuda T; Takayama K; Hirata M; Liu YJ; Yanagihara K; Suga M; Mizuguchi H; Furue MK
    Exp Cell Res; 2017 Mar; 352(2):333-345. PubMed ID: 28215634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of Novel 3D Culture Systems for Studies of Human Liver Function and Assessments of the Hepatotoxicity of Drugs and Drug Candidates.
    Andersson TB
    Basic Clin Pharmacol Toxicol; 2017 Oct; 121(4):234-238. PubMed ID: 28470941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a Three-Dimensional Primary Human Hepatocyte Spheroid Model: Adoption and Industrialization for the Enhanced Detection of Drug-Induced Liver Injury.
    Schofield CA; Walker TM; Taylor MA; Patel M; Vlachou DF; Macina JM; Vidgeon-Hart MP; Williams A; McGill PJ; Newman CF; Sakatis MZ
    Chem Res Toxicol; 2021 Dec; 34(12):2485-2499. PubMed ID: 34797640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utilization of causal reasoning of hepatic gene expression in rats to identify molecular pathways of idiosyncratic drug-induced liver injury.
    Laifenfeld D; Qiu L; Swiss R; Park J; Macoritto M; Will Y; Younis HS; Lawton M
    Toxicol Sci; 2014 Jan; 137(1):234-48. PubMed ID: 24136188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NADPH-cytochrome P450 reductase expression and enzymatic activity in primary-like human hepatocytes and HepG2 cells for in vitro biotransformation studies.
    Schulz C; Kammerer S; Küpper JH
    Clin Hemorheol Microcirc; 2019; 73(1):249-260. PubMed ID: 31561354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and disease.
    Bell CC; Hendriks DF; Moro SM; Ellis E; Walsh J; Renblom A; Fredriksson Puigvert L; Dankers AC; Jacobs F; Snoeys J; Sison-Young RL; Jenkins RE; Nordling Å; Mkrtchian S; Park BK; Kitteringham NR; Goldring CE; Lauschke VM; Ingelman-Sundberg M
    Sci Rep; 2016 May; 6():25187. PubMed ID: 27143246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional, Functional, and Mechanistic Comparisons of Stem Cell-Derived Hepatocytes, HepaRG Cells, and Three-Dimensional Human Hepatocyte Spheroids as Predictive In Vitro Systems for Drug-Induced Liver Injury.
    Bell CC; Lauschke VM; Vorrink SU; Palmgren H; Duffin R; Andersson TB; Ingelman-Sundberg M
    Drug Metab Dispos; 2017 Apr; 45(4):419-429. PubMed ID: 28137721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HepaRG culture in tethered spheroids as an in vitro three-dimensional model for drug safety screening.
    Wang Z; Luo X; Anene-Nzelu C; Yu Y; Hong X; Singh NH; Xia L; Liu S; Yu H
    J Appl Toxicol; 2015 Aug; 35(8):909-17. PubMed ID: 25512232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A two-step strategy to expand primary human hepatocytes in vitro with efficient metabolic and regenerative capacities.
    Xie H; Li G; Fu Y; Jiang N; Yi S; Kong X; Shi J; Yin S; Peng J; Jiang Y; Lu S; Deng H; Xie B
    Stem Cell Res Ther; 2024 Sep; 15(1):281. PubMed ID: 39227965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of human hepatocyte spheroids without feeder cells for evaluation of hepatotoxicity.
    Ogihara T; Arakawa H; Jomura T; Idota Y; Koyama S; Yano K; Kojima H
    J Toxicol Sci; 2017; 42(4):499-507. PubMed ID: 28717109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.